Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2018-11-01 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2018. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in the company's capital structure and share issuance activities during a specific month. There are no financial statements, earnings data, or management discussion of results. The document is a regulatory filing reporting monthly share capital movements to the stock exchange (Hong Kong Exchanges and Clearing Limited). This type of document fits the category of Share Issue/Capital Change (SHA) as it reports on share capital changes and issuance activities.
2018-11-01 English
Announcement of Dividend Policy
Regulatory Filings Classification · 95% confidence The document is an announcement titled 'ANNOUNCEMENT OF DIVIDEND POLICY' made by the company pursuant to listing rules and securities ordinance. It discusses the adoption of a dividend policy by the board of directors, outlining the approach to dividends but does not declare a specific dividend amount or payment date. The document is relatively short (1977 characters) and serves as a policy announcement rather than a dividend payment notice or financial report. It does not contain financial statements or results, nor does it announce actual dividend amounts. Therefore, it fits best under the category of Notice of Dividend Amount (DIV) only if it announces dividend amounts, which it does not. Instead, it is an announcement about the dividend policy itself, which is closest to a Regulatory Filing (RNS) as it is a regulatory announcement that does not fit other categories. However, since the document is specifically about dividend policy and not a general regulatory filing, and given the definitions, the best fit is Regulatory Filings (RNS) as a fallback for miscellaneous announcements that do not fit other categories.
2018-10-26 English
Terms of Reference of Nomination Committee
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of Nomination Committee' and details the formation, composition, duties, and authority of the Nomination Committee of Guangdong Tannery Limited. It focuses on governance aspects such as board structure, nomination policies, and committee procedures. There is no financial data, earnings information, or regulatory filing content. The content aligns with governance practices and internal rules regarding board nominations and committee operations. Therefore, the document fits best under Governance Information (CGR). The document length is 3503 characters, which is not a brief announcement but a detailed governance document.
2018-10-26 English
Unaudited Financial Information for the nine months ended 30 September 2018
Interim / Quarterly Report Classification · 95% confidence The document is titled 'UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2018' and contains detailed financial data including revenue, loss attributable to shareholders, total assets, and shareholders' equity for the nine-month period ending 30 September 2018. It explicitly states that the financial information is unaudited and is for a period shorter than a full fiscal year, which aligns with an interim or quarterly report. The document includes comparative figures for the prior year and discusses operational highlights and financial performance in detail. It is not a full annual report (10-K), nor is it an earnings release (which typically contains only key highlights). It is not a mere announcement of a report but contains substantive financial data and analysis. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). The document length (6571 characters) supports that it is a substantive report rather than a brief announcement or certification. Hence, the classification is IR with high confidence. 9M 2018
2018-10-26 English
Date of Board Meeting
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangdong Tannery Limited regarding the date of a board meeting to approve the announcement of unaudited financial information for the nine months ended 30 September 2018. The document is short (1343 characters) and does not contain any actual financial data or detailed financial statements. It is a notice about an upcoming event related to financial reporting, not the report itself. According to the 'MENU VS MEAL' rule, such announcements are classified as Regulatory Filings (RNS) rather than Interim/Quarterly Reports (IR) or Earnings Releases (ER).
2018-10-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/9/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions during the month. The content is focused on changes in the company's share capital structure and related securities movements for a specific month. This type of document is a regulatory filing that reports monthly share capital movements to the exchange, not a full financial report, earnings release, or management discussion. It is not an announcement of a report publication but a periodic regulatory submission. Therefore, the most appropriate classification is 'Regulatory Filings' (RNS), as it is a compliance document reporting share capital movements without substantive financial statements or analysis.
2018-10-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.